Quantessence Capital’s Tenet Healthcare THC Stock Holding History

Quantessence Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,700	Closed	-$2.38M	–	421
2025 Q1	$2.38M	Buy	+17,700	New	+$2.33M	0.6%	34

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quantessence Capital's THC Position: Q2 2025 in Review

Quantessence Capital sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 17,700 shares — an estimated $2.38M sold.

Quantessence Capital first reported a position in THC in Q1 2025 and held it in 1 quarter. The position peaked at $2.38M in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Quantessence Capital reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 17,700 Tenet Healthcare shares in Q2 2025, an estimated $2.38M.
Quantessence Capital first reported a position in Tenet Healthcare in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Tenet Healthcare position peaked at $2.38M in Q1 2025.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.